[Nasopharyngeal hemangioma].
Szlezak L, Sawiński P.
Otolaryngol Pol. 1974;28(3):329-30.
Childhood Vascular Tumors Treatment (PDQ®): Health Professional Version.
PDQ Pediatric Treatment Editorial Board.
2025 Apr 17. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–.
JUVENILE NASOPHARYNGEAL ANGIOFIBROMA.
PATTERSON CN.
Arch Otolaryngol. 1965 Mar;81:270-7. doi: 10.1001/archotol.1965.00750050279018.
Juvenile nasopharyngeal angiofibroma.
DIBBLE PA, KING HC.
Laryngoscope. 1962 Feb;72:218-31. doi: 10.1288/00005537-196202000-00009.
Less common extracerebral tumors.
Ganz JC.
Prog Brain Res. 2022;268(1):279-302. doi: 10.1016/bs.pbr.2021.10.037. Epub 2022 Jan 6.
Endonasal approaches for sinonasal and nasopharyngeal tumors.
Rice DH.
Otolaryngol Clin North Am. 2001 Dec;34(6):1087-93, viii. doi: 10.1016/s0030-6665(05)70367-4.
Developmental nasal anomalies.
Morgan DW, Evans JN.
J Laryngol Otol. 1990 May;104(5):394-403. doi: 10.1017/s0022215100158542.
NASOPHARYNGEAL ANGIOFIBROMA.
FURSTENBERG AC, BOLES R.
Trans Am Acad Ophthalmol Otolaryngol. 1963 Jul-Aug;67:518-23.
Nasopharyngeal angiofibromas.
HUBBARD EM.
AMA Arch Pathol. 1958 Feb;65(2):192-204.
Childhood Vascular Tumors (PDQ®): Patient Version.
PDQ Pediatric Treatment Editorial Board.
2025 Mar 6. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–.
